Stockreport

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares [Yahoo! Finance]

Qualigen Therapeutics, Inc.  (QLGN) 
PDF a life science company focused on developing platform treatments for adult and pediatric cancers, with the potential for orphan drug designations, announced today that i [Read more]